Strome Group, Inc. insider trades: Zivo Bioscience (ZIVO) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Strome Group, Inc. reports to the SEC
Open-market buys and sales
4 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Feb 12, 2026 | ZIVO | ↑ Buy | 20,000 | $9.77 | $195K | By entity | Feb 17, 2026 (5d) |
| Oct 13, 2025 | ZIVO | ↑ Buy | 20,259 | $12.34 | $250K | By entity | Oct 20, 2025 (7d) |
| Dec 26, 2024 | ZIVO | ↑ Buy | 75,000 | $20.19 | $1.5M | By entity | Dec 31, 2024 (5d) |
| Jun 2, 2021 | ZIVO | ↑ Buy | 40,000 | $4.99 | $200K | By trust | Oct 30, 2023 (880d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other ZIVO insiders
Open-market trades in the last 12 months
About Strome Group, Inc.'s insider trades
Strome Group, Inc. is an insider at Zivo Bioscience (ZIVO). Since Jun 2, 2021, it has reported 4 open-market purchases worth $2.2M and no sales on SEC Form 4. In the last 12 months: 1 buy ($195K).
Its filings also include other transactions (7 filings), conversions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ZIVO insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.